Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOncology Institute Inc (The) Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2026 | 3 | -$0.07 | -$0.06 | -$0.06 |
| Q3 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2026 | 1 | -$0.04 | -$0.03 | -$0.04 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
Oncology Institute Inc (The) Earnings Date And Information
Oncology Institute Inc (The) last posted its earnings results on Thursday, March 12th, 2026. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.02. The company had revenue of 141.96 M for the quarter and had revenue of 502.73 M for the year. Oncology Institute Inc (The) has generated $-1 earnings per share over the last year ($-0.54 diluted earnings per share) and currently has a price-to-earnings ratio of -63.95. Oncology Institute Inc (The) has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Oncology Institute Inc (The) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 2025 | -$0.08 | -$0.04 | 0.04 | $139.79 M | $141.96 M |
| 11/13/2025 | Q3 2025 | -$0.12 | -$0.14 | -0.02 | $122.63 M | $136.56 M |
| 08/13/2025 | Q2 2025 | -$0.14 | -$0.15 | -0.01 | $113.32 M | $119.80 M |
| 05/14/2025 | Q1 2025 | N/A | -$0.21 | N/A | N/A | $104.41 M |
| 03/25/2025 | Q4 2024 | N/A | -$0.14 | N/A | $109.15 M | $100.27 M |
| 11/13/2024 | Q3 2024 | -$0.07 | -$0.18 | -0.11 | $107.54 M | $99.90 M |
| 08/13/2024 | Q2 2024 | -$0.10 | -$0.17 | -0.07 | $103.31 M | $98.58 M |
| 05/14/2024 | Q1 2024 | -$0.12 | -$0.22 | -0.1 | $95.17 M | $94.67 M |
| 03/28/2024 | Q4 2023 | N/A | -$0.21 | N/A | N/A | $85.79 M |
| 11/08/2023 | Q3 2023 | -$0.13 | -$0.19 | -0.06 | N/A | $82.04 M |
| 08/09/2023 | Q2 2023 | N/A | -$0.23 | N/A | N/A | $80.22 M |
| 05/10/2023 | Q1 2023 | -$0.17 | -$0.41 | -0.24 | N/A | $76.19 M |
| 03/16/2023 | Q4 2022 | N/A | -$0.13 | N/A | N/A | $71.42 M |
| 11/09/2022 | Q3 2022 | -$0.16 | -$0.03 | 0.13 | N/A | $64.98 M |
| 08/09/2022 | Q2 2022 | N/A | -$0.07 | N/A | N/A | $60.92 M |
| 05/10/2022 | Q1 2022 | N/A | $0.22 | N/A | N/A | $55.16 M |
| 03/11/2022 | Q4 2021 | N/A | -$0.15 | N/A | N/A | $52.30 M |
| 11/08/2021 | Q3 2021 | N/A | -$0.04 | N/A | N/A | $52.28 M |
| 08/16/2021 | Q2 2021 | N/A | $0.05 | N/A | N/A | $49.84 M |
| 05/28/2021 | Q1 2021 | N/A | -$0.02 | N/A | N/A | $48.58 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oncology Institute Inc (The) Earnings: FAQ's
In the previous quarter, Oncology Institute Inc (The) (:TOI) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.02.
The conference call for Oncology Institute Inc (The)'s latest earnings report can be listened to online.
The conference call transcript for Oncology Institute Inc (The)'s latest earnings report can be read online.
Oncology Institute Inc (The) (:TOI) has a recorded annual revenue of $502.73 M.
Oncology Institute Inc (The) (:TOI) has a recorded net income of $-60,606,000.Oncology Institute Inc (The) has generated $-0.54 earnings per share over the last four quarters.
Oncology Institute Inc (The) (:TOI) has a price-to-earnings ratio of -63.95 and price/earnings-to-growth ratio is -2.31.